Blinatumomab Now Indicated for Children with Acute Lymphoblastic Leukemia
September 9th 2016The FDA has expanded the use of Amgen's blinatumomab (Blincyto) to treat Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in pediatric patients.
Read More
A Closer Look at Hillary Clinton's Pharmaceutical Policy Proposals
September 9th 2016Although Democratic presidential candidate Hillary Clinton's prescription plan was released almost a year ago, the former Secretary of State's intentions for dealing with the pharmaceutical industry were back in the news last week.
Read More